EnQuest PLC -- s. 38(3)

March 17, 2010

Attention: Viviana Beltrametti Walker

Further to your letter of March 10, 2010 and email of March 16, 2010 (collectively, the Letter), we understand that:

1. Selling shareholders are proposing to make an offering of ordinary shares of EnQuest to certain institutional investors in the United Kingdom, Sweden and elsewhere outside the United States, including Ontario, Canada.

2. Prospective purchasers, who must be Accredited Investors and/or Permitted Clients in Ontario, will receive road show materials pertaining to the offering (Road Show Materials) and a Canadian offering memorandum that includes a U.K. prospectus (the UK Prospectus), including any offering documents ancillary thereto, and a Canadian supplement.

3. The managers for the offering will rely on appropriate exemptions from the prospectus requirements, and will either rely on the "international dealer" exemption to the registration requirements, or will be appropriately registered under the Securities Act (Ontario), when distributing securities to residents of Ontario.

4. EnQuest intends to make applications to the UK Listing Authority for the ordinary shares to be admitted to the Official List and to the London Stock Exchange for the ordinary shares to be admitted to trading on the London Stock Exchange's main market for listed securities and to the NASDAQ OMX Stockholm AB for the ordinary shares to be admitted to trading on the NASDAQ OMX.

5. The Road Show Materials and the UK Prospectus, including any offering documents ancillary thereto, will contain one or more representations identical or substantially similar to the following (the Listing Representations): (a) application will be made to the [Financial Services Authority (FSA)] for all the Ordinary Shares to be admitted to the Official List of the FSA with a premium listing and to the London Stock Exchange for such Ordinary Shares to be admitted to trading on the London Stock Exchange's main market for listed securities ("London Admission"), (b) it is expected that London Admission will become effective and that unconditional dealings will commence in the Ordinary Shares on the London Stock Exchange at 8:00 a.m. (London time) on 6 April 2010, (c) application will also be made to NASDAQ OMX Stockholm AB for all of the Ordinary Shares, issues and to be issued, to be secondary listed on NASDAQ OMX Stockholm ("Stockholm Admission") and (d) it is expected that Stockholm Admission will become effective and that unconditional dealings in the Ordinary Shares will commence on NASDAQ OMX Stockholm at 9:00 a.m. (Stockholm time) on 9 April 2010.

6. The FSA has not granted approval to the admission to the Official List of the FSA, the London Stock Exchange has not granted approval, and the NASDAQ OMX Stockholm AB has not granted approval to the admission to the NASDAQ OMX for the listing of the ordinary shares, conditional or otherwise, nor have they consented to, nor indicated that they do not object to the Listing Representations.

7. The UK Prospectus discloses that all dealings in the ordinary shares on the London Stock Exchange are conditional on London Admission, and that all dealings in the ordinary shares on the NASDAQ OMX are conditional on the Stockholm Admission.

8. The Filer seeks permission to include the Listing Representation in the Road Show Materials and the UK Prospectus, including any offering documents ancillary thereto, to be provided to or made available to prospective Ontario purchasers.

Based upon the representations above and the representations contained in the Letter, permission is hereby granted pursuant to subsection 38(3) of the Securities Act (Ontario) to include the Listing Representation in the Road Show Materials and the UK Prospectus, including any offering documents ancillary thereto, to be provided to or made available to prospective Ontario purchasers.

Yours very truly,